Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA halts pediatric study of Amgen's Sensipar after death
FDA halts pediatric study of Amgen's Sensipar after death
FDA halts pediatric study of Amgen's Sensipar after death
Submitted by
admin
on March 1, 2013 - 12:00pm
Source:
Fierce Pharma
News Tags:
Sensipar
Amgen
FDA
clinical trials
hyperparathyroidism
Headline:
FDA halts pediatric study of Amgen's Sensipar after death
Do Not Allow Advertisers to Use My Personal information
